生物活性 | |||
---|---|---|---|
描述 | Methocarbamol is a commonly used, centrally acting muscle relaxant and has not been linked to instances of liver injury[3]. Methocarbamol is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. Absorption and elimination of methocarbamol is similar between normal subjects and patients undergoing maintenance haemodialysis[4]. Patients who were treated with methocarbamol showed a significant decrease in the frequency and duration of cramps. Also, the pain score improved significantly. Methocarbamol seems to be a promising safe and well-tolerated medication, and plays a role in the treatment of muscle cramps in patients with liver cirrhosis[5]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00770497 | Inflammation ... 展开 >>Hypertension 收起 << | Phase 2 | Completed | - | Germany ... 展开 >> Deggingen, Baden-Württemberg, Germany Rottweil, Baden-Württemberg, Germany Spaichingen, Baden-Württemberg, Germany Weilersbach, Bayern, Germany Hannover, Niedersachsen, Germany Essen, Nordrhein-Westfalen, Germany Köln, Nordrhein-Westfalen, Germany Werne, Nordrhein-Westfalen, Germany Mainz, Rheinland-Pfalz, Germany Schauenburg, Rheinland-Pfalz, Germany Dresden, Sachsen, Germany Blankenhain, Thüringen, Germany Berlin, Germany 收起 << |
NCT02707094 | Chronic Low Back Pain | Not Applicable | Completed | - | United States, Texas ... 展开 >> Brooke Army Medical Center Fort Sam Houston, Texas, United States, 78234 收起 << |
NCT02669875 | Liver Cirrhosis ... 展开 >> Hypertension, Portal 收起 << | Phase 2 | Completed | - | United Kingdom ... 展开 >> Liver Unit, Royal Infirmary of Edinburgh Edinburgh, United Kingdom, EH164TJ 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
4.15mL 0.83mL 0.41mL |
20.73mL 4.15mL 2.07mL |
41.45mL 8.29mL 4.15mL |
参考文献 |
---|